Oct 23, 2023 | Press Releases
Post-merger, the combined company, operating under the name “NAYA Biosciences”, will be dedicated to increasing patient access to life-transforming treatments in oncology, fertility, and regenerative medicineNAYA will seek to scale up profitable revenues...
Oct 11, 2023 | Press Releases
SARASOTA, Fla., Oct. 11, 2023 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and...
Sep 29, 2023 | Press Releases
SARASOTA, Fla., Sept. 29, 2023 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”) today announced that its special meeting of shareholders on September 29, 2023 (the “Special Meeting”) was convened and then...
Sep 28, 2023 | Press Releases
SARASOTA, Fla., Sept. 28, 2023 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device...
Aug 14, 2023 | Press Releases
Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., Aug. 14, 2023 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment...
